Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-07-24
2007-07-24
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387900, C530S388100, C530S389100, C530S391100, C530S391300, C435S007100, C435S007200, C435S007210, C435S007230, C435S007500
Reexamination Certificate
active
11377884
ABSTRACT:
The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.
REFERENCES:
patent: 4690914 (1987-09-01), Callut et al.
patent: 5585103 (1996-12-01), Raychaudhuri et al.
patent: 5593966 (1997-01-01), Malech et al.
patent: 5733748 (1998-03-01), Yu et al.
patent: 5929033 (1999-07-01), Tang et al.
patent: 5985270 (1999-11-01), Srivastava
patent: 6620603 (2003-09-01), Lambeth et al.
patent: 6858386 (2005-02-01), Macina et al.
patent: 2003/0044783 (2003-03-01), Williams et al.
patent: 2003/0109690 (2003-06-01), Ruben et al.
patent: WO 96/39419 (1996-12-01), None
patent: WO 97/42506 (1997-11-01), None
patent: WO 98/44159 (1998-08-01), None
patent: WO 98/44133 (1998-10-01), None
patent: WO 99/01020 (1999-01-01), None
patent: WO 99/24463 (1999-05-01), None
patent: WO 99/25828 (1999-05-01), None
patent: WO 99/47658 (1999-09-01), None
patent: WO 99/53051 (1999-10-01), None
patent: WO 99/55858 (1999-11-01), None
patent: WO 99/60161 (1999-11-01), None
patent: WO 99/63088 (1999-12-01), None
patent: WO 00/07632 (2000-02-01), None
patent: WO 00/12708 (2000-03-01), None
patent: WO 00/28031 (2000-05-01), None
patent: WO 00/32221 (2000-06-01), None
patent: WO 00/37643 (2000-06-01), None
patent: WO 01/96388 (2001-12-01), None
U.S. Appl. No. 60/086,266, filed May 21, 1998, Macina et al.
International Search Report dated Aug. 16, 2000 for PCT/US99/26592.
Abdelrahim, et al., “Liquid chromatographic assay of dityrosin in human cerebrospinal fluid”, J. Chromatogr. B. Biomed. Sci. Appl., vol. 696, pp. 175-182 (1997).
Adams, et al., EMBL Accession No. AA305700, Apr. 18, 1997.
Adams, et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million basepairs of DNA sequence”, EMBL Database Acc No. AA305700, Apr. 18, 1997, XP002137621.
Anderson, “Covalent cross-links in a structural protein, resilin”, Acta Physiol. Scand., vol. 66, Suppl. 263, pp. 1-81 (1966).
Arbiser, et al., “Reactive Oxygen Generated by Nox1 Triggers the Angiogenic Switch,”PNAS, vol. 99, No. 2, pp. 715-720, Jan. 22, 2002.
Banfi, et al., “A Mammalian H+Channel Generated Through Alternative Splicing of the NADPH Oxidase HomologNOH-1,” Science, vol. 287, pp. 138-142, Jan. 7, 2000.
Banfi, et al., GENBANK, Accession No. AF166326, Jan. 6, 2000.
Banfi, et al., GENBANK, Accession No. AF166327, Jan. 6, 2000.
Banfi, et al., GENBANK, Accession No. AF166328, Jan. 6, 2000.
Banfi, et al., GENBANK, Accession No. NM—013955, Apr. 28, 2000.
Bayraktutan, et al., “Molecular Characterization and Localization of the NAD(P)H Oxidase Components gp91-phoxand p22-phoxin Endothelial Cells,”Arterioscler Thromb Vasc Biol., vol. 20, pp. 1903-1911, Aug. 2000.
Burdon, “Superoxide and hydrogen peroxide in relation to mammalian cell proliferation”,Free Radical Biol. Med., vol. 18, No. 4, pp. 775-794 (1995).
Church, et al., “Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells”,Proc. Natl. Acad. Sci. USA, vol. 90, pp. 3113-3117 (1993).
Davis, et al., GENBANK Accession No. O46522, May 30, 2000.
Dupuy, et al., “Purficiation of a novel flavoprotein involved in the thyroid NADPH oxidase”,The Journal of Biological Chemistry, vol. 274, No. 52, Dec. 24, 1999, pp. 37265-37269, XP002144979.
Dupuy, et al., EMBL Database Acc No. AF181972, Dec. 29, 1999, XP002144980.
Edens, et al., J. Cell Biology, vol. 154(4), pp. 879-891 (2001).
Emmendörffer, et al., “Production of oxygen radicals by fibroblasts and neutrophils from a patient with x-linked chronic granulomatous disease”, Eur. J. Haematol, vol. 51, pp. 223-227 (1993).
Fernandez-Pol, et al., “Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclose of sarcoma virus-infected mammalian cells”,Can. Res., vol. 42, pp. 609-617 (1982).
Fire, et al., “Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elegans”, Nature, vol. 391, No. 6669, pp. 806-811 (1998).
Frohman, et al., “Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer”,Proc. Natl. Acad. Sci. USA, vol. 85, pp. 8998-9002 (1988).
Fukui, et al., “p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats”,Cir. Res., vol. 80, No. 1, pp. 45-51 (1997).
Garnder, et al., “Superoxide radical and iron modulate aconitase activity in mammalian cells”, J. Biol. Chem., vol. 270, No. 22, pp. 13399-13405 (1995).
Griendling, et al., “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells”,Cir. Res., vol. 74, No. 6, pp. 1141-1148 (1994).
Griffin, et al., “Initial Clinical Study of Indium-111-Labeled Clone 110 Anticarcinoembryonic Antigen Antibody in Patients with Colorectal Cancer,”Journal of Clinical Oncology, vol. 9, No. 4, pp. 631-640, Apr. 1991.
Haenze, GENBANK, Accession No. AJ438989, Mar. 15, 2002.
Hillier, et al., EMBL Accession No. W52750, Mar. 4, 2000.
Hillier, et al., “Generation and analysis of 280,000 human expressed sequence tags”, EMBL Database Acc No. W52750, Jun. 4, 1996, XP002144976.
International Search Report, dated Aug. 16, 2000 for PCT/US 99/26592.
Irani, et al., “Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts”,Science, vol. 275, No. 5306, pp. 1649-1652 (1997).
Kikuchi, et al., “NADPH Oxidase Subunit gp91phoxHomologue, Preferentially Expressed in Human Colon Epithelial Cells,”Gene, vol. 254, pp. 237-243, 2000.
Lambeth, et al., “Novel Homologs of gp91phox,” TIBS, vol. 25, pp. 459-461, Oct. 2000.
Lauffer, et al., “Targeted Relaxation Enhancement Agents for MRI,”Magnetic Resonance in Medicine, vol. 22, pp. 339-342, 1991.
Leusen, et al., “A Point Mutation in gp91-phoxof Cytochromeb558of the Human NADPH Oxidase Leading to Defective Translocation of the Cytosolic Proteins p47-phoxand p67-phox,” J. Clin. Invest., 93:2120-2126, 1994.
Li, et al., “CD34+ Peripheral Blood Progenitors as a Target for Genetic Correction of the Two Flavocytochrome B558 Defective Forms of Chronic Granulomatous Disease,”Blood, 84(1):53-58, Jul. 1, 1994.
Li, et al., “Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems”, J. Biol. Chem., vol. 273, No. 4, pp. 2015-2023 (1998).
Lloyd, “Human DNA sequence from clone 146h21 on chromosome Xq22”, EMBL Database Acc No.: Z83819, Jan. 10, 1997, XP002137598.
Lloyd, EMBL Accession No. Z83819, Nov. 23, 1999.
Lloyd, GENBANK Accession No. CAB06073, Nov. 23, 1999.
Mastsubara, et al., “Increased superoxide anion release from human endothelial cells in response to cytokines”, J. Immun., vol. 137, No. 10, pp. 3295-3298 (1986).
Meier, et al., “Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α”, Biochem. J., vol. 263, No. 2, pp. 539-545 (1989).
NCBI Annotation Project, GENBANK, Accession No. XP—010073, Aug. 27, 2001.
NCI-CGAP, EMBL Accession No. AA493362, Mar. 3, 2000.
NCI-CGAP, EMBL Accession No. AA641653, Mar. 3, 2000.
Oka, et al., Expression of E-Cadherin Cell Adhesion Molecules in Human Breast Cancer Tissues and Its Relationship to Metastasis,Cancer Research, vol. 53, pp. 1696-1701, Apr. 1, 1993
Arnold Rebecca S.
Cheng Guangjie
Griendling Kathy K.
Lambeth J. David
Lassegue Bernard P.
Crowder Chun
Emory University
Gambel Phillip
Klarquist & Sparkman, LLP
LandOfFree
Mitogenic oxygenases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mitogenic oxygenases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitogenic oxygenases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3787962